Publication
Generative AI
Artificial intelligence (AI) raises many intellectual property (IP) issues.
United States | Publication | February 2022
Norton Rose Fulbright lawyers Roger Kuan and Jason Novak contributed several chapters to Digital Health 2022 International Comparative Legal Guide, published by GLG, which is a leading global platform for legal reference, analysis and news. Kuan also served as a contributing editor for the publication.
Authors: Roger Kuan, Norton Rose Fulbright and David Wallace, Johnson & Johnson
As an introduction into digital health, Kuan expands on the digital technologies in healthcare including healthcare IT, data use, data sharing, intellectual property, commercial agreements, AI and machine learning and liability and the acceleration transformation that was experienced during the pandemic.
Authors: Jason Novak, Norton Rose Fulbright and René Quashie, Consumer Technology Association
Novak explores Digital Therapeutics (DTx), an innovative subset of digital health that has quickly become a new platform for addressing treatment, management and prevention of various disease, as well as any legal and regulatory issues that may arise.
Authors: Roger Kuan and Jason Novak, Norton Rose Fulbright
In this chapter, Kuan and Novak provide answers to key questions regarding digital health and emerging technologies.
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
In February, we reported on the Department of Energy Security and Net Zero’s confirmation that a UK Carbon Border Adjustment Mechanism (CBAM) would be bought into force by 2027
Publication
International financial markets have started to show significant interest in nature and biodiversity. Whilst climate change and greenhouse gas emissions have made the headlines in recent years, there has been much less focus on their equally important counterparts, nature and biodiversity. However, that has started to change.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023